Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geetha Srikrishna

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Journal of Innate Immunity|September 14, 2011
S100A8 and S100A9: new insights into their roles in malignancyGeetha Srikrishna
Neoplasia (New York, N.Y.)|July 2, 2009
Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancerGeetha Srikrishna, Hudson H Freeze
Current HIV/AIDS Reports|May 4, 2017
Mechanisms of HIV-1 ControlMary Soliman, Geetha Srikrishna, Ashwin Balagopal
Biochemical and Biophysical Research Communications|June 1, 2005
Novel carboxylated N-glycans contain oligosaccharide-linked glutamic acidGeetha Srikrishna, Lena Brive, Hudson H Freeze
Glycobiology|January 30, 2014
N-glycosylation deficiency reduces ICAM-1 induction and impairs inflammatory responsePing He, Geetha Srikrishna, Hudson H Freeze
Journal of Infectious Disease and Therapy|May 15, 2024
Mycobacterial Nucleic Acids Modulate Host Innate Immune ResponsesGeetha Srikrishna, C Korin Bullen, William R Bishai
Future Microbiology|July 31, 2015
Can the addition of verapamil to bedaquiline-containing regimens improve tuberculosis treatment outcomes? A novel approach to optimizing TB treatmentGeetha Srikrishna, Shashank Gupta, Kelly E Dooley, et al.
Trends in Immunology|July 16, 2022
Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosisManish Gupta, Geetha Srikrishna, Sabra L Klein, et al.
Molecular Cancer Research : MCR|January 14, 2011
S100A8/A9 activate key genes and pathways in colon tumor progressionMie Ichikawa, Roy Williams, Ling Wang, et al.
Vaccine|October 1, 2021
Recombinant BCGs for tuberculosis and bladder cancerAlok K Singh, Geetha Srikrishna, Trinity J Bivalacqua, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Journal of Innate Immunity|September 14, 2011
S100A8 and S100A9: new insights into their roles in malignancyGeetha Srikrishna
Neoplasia (New York, N.Y.)|July 2, 2009
Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancerGeetha Srikrishna, Hudson H Freeze
Current HIV/AIDS Reports|May 4, 2017
Mechanisms of HIV-1 ControlMary Soliman, Geetha Srikrishna, Ashwin Balagopal
Biochemical and Biophysical Research Communications|June 1, 2005
Novel carboxylated N-glycans contain oligosaccharide-linked glutamic acidGeetha Srikrishna, Lena Brive, Hudson H Freeze
Glycobiology|January 30, 2014
N-glycosylation deficiency reduces ICAM-1 induction and impairs inflammatory responsePing He, Geetha Srikrishna, Hudson H Freeze
Journal of Infectious Disease and Therapy|May 15, 2024
Mycobacterial Nucleic Acids Modulate Host Innate Immune ResponsesGeetha Srikrishna, C Korin Bullen, William R Bishai
Future Microbiology|July 31, 2015
Can the addition of verapamil to bedaquiline-containing regimens improve tuberculosis treatment outcomes? A novel approach to optimizing TB treatmentGeetha Srikrishna, Shashank Gupta, Kelly E Dooley, et al.
Trends in Immunology|July 16, 2022
Genetic and hormonal mechanisms underlying sex-specific immune responses in tuberculosisManish Gupta, Geetha Srikrishna, Sabra L Klein, et al.
Molecular Cancer Research : MCR|January 14, 2011
S100A8/A9 activate key genes and pathways in colon tumor progressionMie Ichikawa, Roy Williams, Ling Wang, et al.
Vaccine|October 1, 2021
Recombinant BCGs for tuberculosis and bladder cancerAlok K Singh, Geetha Srikrishna, Trinity J Bivalacqua, et al.
Pageof 4